Already in the beginning of 2019, the Biopharma Excellence has several good reasons to celebrate. The highlights with major contributions by the Biopharma Excellence team were:
An IND for a first-in-class product was approved by the US FDA.
Two products where Biopharma Excellence was making significant contributions during drug development, dossier preparation and the authorization process obtained marketing authorization in the EU.
Together with our clients, we have been very delighted, and we congratulate the entire team to these great achievements. These are just the first success stories in this year, there are more to come! 🍾